Skip to content

A Controlled Clinical Trial To Assess The Effect Of Kuberaksh Vati And Rajaparvartini Vati In The Management Of Primary Dysmenorrhoea.

A Randomized Open Label Controlled Clinical Study To Evaluate The Efficacy Of Kuberaksh Vati And Rajaparvartini Vati In The Management Of Udavartini Yonivyapad W.S.R. Primary Dysmenorrhoea. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092861
Enrollment
60
Registered
2025-08-12
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N889- Noninflammatory disorder of cervixuteri, unspecified

Interventions

None listed

Sponsors

Institute For Ayurved Studies And Research Sector Kurukshetra Haryana
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient Willing To Give Voluntary Informed Consent Age Group Between 16-35 Years Both Married And Unmarried Women Pain In The Lower Abdomen Which Begin One Or Two Days Before Menstruation Or With The Onset Of Menstruation And Lasting For Few Hours Or One To Two Days Painful Menstruation Also Associated With Symptoms Like Nausea Vomiting Constipation Etc History Of Painful Menstruation For Atleast 3 Consecutive Cycles Patient Diagnosed With Dysmenorrhoea Patient With Regular Menstrual Cycle 21 To 35 Days

Exclusion criteria

Exclusion criteria: Patient Who Is Not Willing To Give Voluntary Informed Consent Patients Taking Any Hormonal Therapy Patients Of Any Pelvic Pathology PCOD PID Cervical stenosis Fibroid Endometriosis Adenomyosis Etc Patients With Congenital Anomalies Of Reproductive System Other Medical Disorders Which Make Patients At High Risk Like Epilepsy Anaemia Hb Less Than 8mg/dl Heart Disease DM Surgical And Malignant Conditions Heavy Bleeding During Menses Patients Are Excluded More Than 4 Pads Fully Soaked Per Day

Design outcomes

Primary

MeasureTime frame
Change In The Grade Of VAS Visual Analogue Score Scale Of PainTimepoint: Follow Up Will Be Done on Day 4 Of Three Consecutive Cycles And 120th day

Secondary

MeasureTime frame
CHANGES IN OTHER ASSOCIATED CLINICAL SYMPTOMS LIKE NAUSEA VOMITING ETCTimepoint: Follow Up Will Be Done On Day 4 Of Three Consecutive Cycles And 120th day

Countries

India

Contacts

Public ContactDr Manju

Institute For Ayurved Studies And Research

drsunititanwar@gmail.com9996311778

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026